New Target for HIV Immune Therapy and Cure to be Explored by Trans-Atlantic Industry-Academia Collaboration
February 20th, 2019 | No Comments
Montreal, Canada and London, UK, February 20, 2019
The NEOMED Institute (NEOMED), GlaxoSmithKline Inc. (GSK), the Centre Hospitalier de l'Université de Montréal (CHUM) Research Centre and University College London (UCL) are pleased to announce that they have entered into a strategic collaboration to explore the potential of a
Read complete news
Support for the NEOMED Institute for the implementation of an innovation and commercialization complex
MONTRÉAL, Dec. 7, 2018 - The City of Montréal and the Government of Canada announced today their financial support for the NEOMED Institute for the implementation of a new innovation and commercialization complex (ICC), specializing in life sciences and health technology (LSHT). This complex will provide SMEs with customized labs, shared equi
Read complete news
NEOMED Institute Announces the Appointment of Dr. Youssef Bennani to its Board of Directors
Montreal, Quebec, November 14, 2018 – NEOMED Institute announced today that experienced bio-pharmaceutical scientist and executive Dr. Youssef Bennani has joined its Board of Directors.
Dr. Youssef Bennani is currently Chairman of the Board of Domain Therapeutics (France & Canada), and is an independent Board member of
Read complete news
Ampersand Invests in Management Buyout of Clinical Immunology Provider NEOMED-LABS from the NEOMED Institute
LAVAL, QC. and WELLESLEY, MA., September 4, 2018 – Ampersand Capital Partners, together with the management team of NEOMED-LABS and the NEOMED Institute, announced today that Ampersand has partnered with management in the acquisition of NEOMED-LABS from its not-for-profit founder and parent, the NEOMED Institute.
NEOMED-LABS i
Read complete news
